CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-25 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −25,974 | 29,026 | ||
| 2020-02-25 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +55,000 | 55,000 | ||
| 2020-02-25 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −25,974 | 29,026 | ||
| 2020-02-25 | Kennedy Joseph T General Counsel | Option exercise | +30,697 | 191,522 | ||
| 2020-02-25 | Kennedy Joseph T General Counsel | Option exercise | +30,697 | 222,219 | ||
| 2020-02-25 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −32,324 | $17.58 | $568K | 189,895 |
| 2020-02-25 | Kennedy Joseph T General Counsel | Grant or award · Restricted Stock Units | +65,000 | 65,000 | ||
| 2020-02-25 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −30,697 | 34,303 | ||
| 2020-02-25 | Kennedy Joseph T General Counsel | Grant or award · Restricted Stock Units | +65,000 | 65,000 | ||
| 2020-02-25 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −30,697 | 34,303 | ||
| 2020-02-25 | THERO JOHN F President and CEO | Option exercise | +114,515 | 2,647,880 | ||
| 2020-02-25 | THERO JOHN F President and CEO | Option exercise | +114,515 | 2,762,395 | ||
| 2020-02-25 | THERO JOHN F President and CEO | Shares withheld for taxes | −90,124 | $17.58 | $1.6M | 2,672,271 |
| 2020-02-25 | THERO JOHN F President and CEO | Grant or award · Restricted Stock Units | +242,500 | 242,500 | ||
| 2020-02-25 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −114,515 | 127,985 | ||
| 2020-02-25 | THERO JOHN F President and CEO | Grant or award · Restricted Stock Units | +242,500 | 242,500 | ||
| 2020-02-25 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −114,515 | 127,985 | ||
| 2020-02-03 | THERO JOHN F President and CEO | Grant or award · Stock Option (Right to Buy) | +350,700 | 350,700 | ||
| 2020-02-03 | Kennedy Joseph T General Counsel | Grant or award · Stock Option (Right to Buy) | +96,500 | 96,500 | ||
| 2020-02-03 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +96,500 | 96,500 |
Page 57 of 67 · 1,339 trades